-
1
-
-
20044382229
-
Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches. The GRADE Working Group
-
Atkins D, Eccles M, Flottorp S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches. The GRADE Working Group. BMC Health Serv Res, 2004, 4(1): 38.
-
(2004)
BMC Health Serv Res
, vol.4
, Issue.1
, pp. 38
-
-
Atkins, D.1
Eccles, M.2
Flottorp, S.3
-
2
-
-
0742266220
-
Surprising results of randomized trials
-
Guyatt G, Drummond R, eds, Chicago, IL: AMA Press
-
Lacchetti C, Guyatt G. Surprising results of randomized trials. In: Guyatt G, Drummond R, eds. Users' guides to the medical literature: a manual of evidence-based clinical practice. Chicago, IL: AMA Press, 2002.
-
(2002)
Users' guides to the medical literature: A manual of evidence-based clinical practice
-
-
Lacchetti, C.1
Guyatt, G.2
-
3
-
-
0026464712
-
Guidelines for counseling postmenopausal women about preventive hormone therapy
-
American College of Physicians
-
American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med, 1992, 117(12): 1038-1041.
-
(1992)
Ann Intern Med
, vol.117
, Issue.12
, pp. 1038-1041
-
-
-
4
-
-
0037143553
-
Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease
-
Humphrey LL, Chan BK, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med, 2002, 137(4): 273-284.
-
(2002)
Ann Intern Med
, vol.137
, Issue.4
, pp. 273-284
-
-
Humphrey, L.L.1
Chan, B.K.2
Sox, H.C.3
-
5
-
-
0032547326
-
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group
-
Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA, 1998, 280(7): 605-613.
-
(1998)
JAMA
, vol.280
, Issue.7
, pp. 605-613
-
-
Hulley, S.1
Grady, D.2
Bush, T.3
-
6
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
-
Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA, 2002, 288(3): 321-333.
-
(2002)
JAMA
, vol.288
, Issue.3
, pp. 321-333
-
-
Rossouw, J.E.1
Anderson, G.L.2
Prentice, R.L.3
-
7
-
-
0026011647
-
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial
-
Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med, 1991, 324(12): 781-788.
-
(1991)
N Engl J Med
, vol.324
, Issue.12
, pp. 781-788
-
-
Echt, D.S.1
Liebson, P.R.2
Mitchell, L.B.3
-
8
-
-
0026652402
-
A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction
-
Antman EM, Lau J, Kupelnick B, et al. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA, 1992, 268(2): 240-248.
-
(1992)
JAMA
, vol.268
, Issue.2
, pp. 240-248
-
-
Antman, E.M.1
Lau, J.2
Kupelnick, B.3
-
9
-
-
0020472723
-
Aspirin and Reye syndrome
-
Committee on Infectious Diseases
-
Committee on Infectious Diseases. Aspirin and Reye syndrome. Pediatrics, 1982, 69(6): 810-812.
-
(1982)
Pediatrics
, vol.69
, Issue.6
, pp. 810-812
-
-
|